Current Drug Targets

Editor-in-Chief

Francis J. Castellino
(14643 citations)
Kleiderer-Pezold Professor of Biochemistry
Director, W.M. Keck Center for Transgene Research
Dean Emeritus, College of Science
230 Raclin-Carmichael Hall, University of Notre Dame
Notre Dame, IN 46556
(USA)

Personal Subscription
Become EABM
Become Reviewer

Most Accessed Articles

New Anti-VEGF Drugs in Ophthalmology

Volume: 21   Issue: 12
Pp: 1194-1200
Claudio Campa *
DOI: 10.2174/1389450121666200428101738

Targeting Cancer Stem Cells Pathways for the Effective Treatment of Cancer

Volume: 21   Issue: 3
Pp: 258-278
Ashish Ranjan Dwivedi, Amandeep Thakur, Vijay Kumar, Ira Skvortsova and Vinod Kumar*
DOI: 10.2174/1389450120666190821160730

Edaravone May Prevent Ferroptosis in ALS

Volume: 21   Issue: 8
Pp: 776-780
Snežana Spasić*, Aleksandra Nikolić-Kokić, Srđan Miletić, Zorana Oreščanin-Dušić, Mihajlo B. Spasić, Duško Blagojević and Zorica Stević
DOI: 10.2174/1389450121666200220123305

Targeting Autophagic Pathways by Plant Natural Compounds in Cancer Treatment

Volume: 21   Issue: 12
Pp: 1237-1249
Fatemeh Forouzanfar and Seyed Hadi Mousavi*
DOI: 10.2174/1389450121666200504072635

The Epigenetic Modification of Epigallocatechin Gallate (EGCG) on Cancer

Volume: 21   Issue: 11
Pp: 1099-1104
Linqi Yang, Wenqi Zhang, Saiyam Chopra, Deeepjyot Kaur, Huibing Wang, Meng Li, Pingping Chen* and Wei Zhang*
DOI: 10.2174/1389450121666200504080112

Application of Artificial Intelligence in Targeting Retinal Diseases

Volume: 21   Issue: 12
Pp: 1208-1215
Francesco Saverio Sorrentino, Giuseppe Jurman, Katia De Nadai, Claudio Campa, Cesare Furlanello and Francesco Parmeggiani*
DOI: 10.2174/1389450121666200708120646

N6-methyladenine RNA Modification (m6A): An Emerging Regulator of Metabolic Diseases

Volume: 21   Issue: 11
Pp: 1056-1067
Hui Zhong, Hui-Fang Tang and Yin Kai*
DOI: 10.2174/1389450121666200210125247

Fluoroquinolones: Blessings Or Curses

Volume: 21   Issue: 13
Pp: 1354-1370
Priyanka P. Majalekar* and Pramodkumar J. Shirote
DOI: 10.2174/1389450121666200621193355

IL-37 As a Potential Biotherapeutics of Inflammatory Diseases

Volume: 21   Issue: 9
Pp: 855-863
Junhui Bai, Yukun Li, Meixiang Li, Sijie Tan* and Daichao Wu*
DOI: 10.2174/1389450121666200429114926

Medicinal Perspective of Indole Derivatives: Recent Developments and Structure-Activity Relationship Studies

Volume: 21   Issue: 9
Pp: 864-891
Devendra Kumar, Sahil Sharma, Sourav Kalra, Gurpreet Singh, Vikramdeep Monga and Bhupinder Kumar*
DOI: 10.2174/1389450121666200310115327

Advances in the Treatment of Ovarian Cancer Using PARP Inhibitors and the Underlying Mechanism of Resistance

Volume: 21   Issue: 2
Pp: 167-178
Ling Wang, Qi Wang, Yangchun Xu, Manhua Cui and Liying Han*
DOI: 10.2174/1389450120666190925123507

Chitosan Nanoparticles as a Novel Drug Delivery System: A Review Article

Volume: 21   Issue: 15
Pp: 1613-1624
Sina M. Matalqah*, Khalid Aiedeh, Nizar M. Mhaidat, Karem H. Alzoubi, Yasser Bustanji and Islam Hamad
DOI: 10.2174/1389450121666200711172536

Targeting Host Cell Proteases to Prevent SARS-CoV-2 Invasion

Volume: 22   Issue: 2
Pp: 192-201
Upinder Kaur, Sankha Shubhra Chakrabarti*, Bisweswar Ojha, Bhairav Kumar Pathak, Amit Singh, Luciano Saso and Sasanka Chakrabarti
DOI: 10.2174/1389450121666200924113243

The Potential of PI3K/AKT/mTOR Signaling as a Druggable Target for Endometrial and Ovarian Carcinomas

Volume: 21   Issue: 10
Pp: 946-961
Csongor György Lengyel*, Sara Cecilia Altuna, Baker Shalal Habeeb, Dario Trapani and Shah Zeb Khan
DOI: 10.2174/1389450120666191120123612

Anti-VEGF Treatment in Corneal Diseases

Volume: 21   Issue: 12
Pp: 1159-1180
Giuseppe Giannaccare, Marco Pellegrini, Cristina Bovone, Rossella Spena, Carlotta Senni, Vincenzo Scorcia and Massimo Busin*
DOI: 10.2174/1389450121666200319111710